Veracyte (VCYT)
(Delayed Data from NSDQ)
$34.83 USD
-0.42 (-1.19%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $34.87 +0.04 (0.11%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for Veracyte, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -74.40 | -36.56 | -75.56 | -34.91 | -12.60 |
Depreciation/Amortization & Depletion | 27.19 | 25.93 | 19.59 | 7.94 | 4.20 |
Net Change from Assets/Liabilities | -4.16 | -16.38 | 4.22 | -0.48 | -4.85 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 95.60 | 34.55 | 20.13 | 17.74 | 10.01 |
Net Cash From Operating Activities | 44.22 | 7.54 | -31.62 | -9.71 | -3.23 |
Property & Equipment | -9.96 | -8.55 | -5.38 | -2.84 | -2.73 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -736.83 | 0.00 | -40.00 |
Investments | 25.07 | -20.84 | 3.00 | -1.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 15.11 | -29.39 | -739.21 | -3.84 | -42.73 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 9.58 | 7.94 | 605.35 | 207.54 | 152.50 |
Issuance (Repayment) of Debt | 0.00 | -1.28 | 0.00 | -0.10 | -25.21 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -6.74 | -3.17 | -9.03 | -3.85 | 0.00 |
Net Cash from Financing Activities | 2.84 | 3.49 | 596.32 | 203.60 | 127.29 |
Effect of Exchange Rate Changes | 0.16 | -0.59 | -1.51 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 62.33 | -18.95 | -176.02 | 190.05 | 81.32 |
Cash at Beginning of Period | 155.00 | 173.95 | 349.97 | 159.92 | 78.60 |
Cash at End of Period | 217.33 | 155.00 | 173.95 | 349.97 | 159.92 |
Diluted Net EPS | -1.02 | -0.51 | -1.11 | -0.66 | -0.27 |
Fiscal Year End for Veracyte, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3.87 | -1.86 | -74.40 | -46.11 | -16.49 |
Depreciation/Amortization & Depletion | 11.33 | 5.59 | 27.19 | 20.85 | 13.53 |
Net Change from Assets/Liabilities | -17.03 | -22.83 | -4.16 | -5.59 | -4.04 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 22.44 | 10.14 | 95.60 | 59.52 | 21.50 |
Net Cash From Operating Activities | 20.61 | -8.97 | 44.22 | 28.67 | 14.50 |
Property & Equipment | -4.90 | -2.13 | -9.96 | -7.46 | -4.66 |
Acquisition/ Disposition of Subsidiaries | 5.01 | 5.01 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 25.07 | 25.07 | 25.07 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.11 | 2.88 | 15.11 | 17.61 | 20.41 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.26 | 2.97 | 9.58 | 7.81 | 5.25 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -5.14 | -3.83 | -6.74 | -5.61 | -3.17 |
Net Cash from Financing Activities | -0.88 | -0.86 | 2.84 | 2.19 | 2.08 |
Effect of Exchange Rate Changes | -0.17 | -0.11 | 0.16 | -0.13 | 0.04 |
Net Change In Cash & Equivalents | 19.67 | -7.06 | 62.33 | 48.34 | 37.04 |
Cash at Beginning of Period | 217.33 | 217.33 | 155.00 | 155.00 | 155.00 |
Cash at End of Period | 237.00 | 210.27 | 217.33 | 203.33 | 192.03 |
Diluted Net EPS | 0.07 | -0.02 | -0.38 | -0.41 | -0.12 |